# Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants

> **NCT03718507** · PHASE1 · WITHDRAWN · sponsor: **ASST Fatebenefratelli Sacco**

## Conditions studied

- Respiratory Distress Syndrome
- Surfactant Deficiency Syndrome Neonatal
- Near Infrared Spectroscopy

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Sucrose 24% Oral Solution

## Key facts

- **NCT ID:** NCT03718507
- **Lead sponsor:** ASST Fatebenefratelli Sacco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-20
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no recrutiment started
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718507, "Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03718507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*